skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: In answer to @Cheryl, Knight released two news yesterday. The Triumvira repayment shows that Goodman's strategy of battling mostly 'singles' (except the GBT 'homerun') is working.

However, a more meaningful news is that Knight finished repurchasing 100% of their shares buyback under their NCIB. I don't recall a company actually buying "all" of the NCIB allocation. We knew they had bought 78% of it as of March 30, 20 in their Q4 2019 quarterly report. We could have expected they would buy the other 18% but still did it quickly with Stock having dropped a lot in the COVID market (even though they said COVID had not affected their business - well not yet at least).

Question: their NCIB only expires on July 8. Does it mean GUD has to wait until July 8 to request another NCIB to the TSX if they want to continue buying back their shares? Medison still owns 7.5% (10.5M shares) of the company, and I would really like to have GUD arrange a 'block' buyback of Medison's Shares via a 'special NCIB' repurchase to finish the Meir Jacobson involvement once and for all without disrupting the share price, or at least causing uncertainty/concern on that.

Is that possible? And if so, does it have to wait until current NCIB expires in July even as they have completed 100% of the current NCIB already? Thank you!
Read Answer Asked by Jennifer on April 17, 2020
Q: May I have your opinion on CloudMD Software (DOC.CN)? Telemedicine may benefit in this environment.
Read Answer Asked by Manoj on April 17, 2020
Q: Hello Peter & Team,

I have been patiently holding VMD since the early November 2019 drop expecting this to be a company leaned on during the current pandemic. Today it is up 14%. Is there a reason for this jump? And what are your expectations moving forward?

I did read the article posted earlier today.

Thanks for all you do

gm
Read Answer Asked by Gord on April 14, 2020
Q: Would you please tell me what you know about this company and how to invest in it. Do you think it has possibilities positive possibilities? Thank you. Anne
Read Answer Asked by M Anne on April 14, 2020
Q: Can you recommend a good ETF probably US based, which has companies in the forefront of corona vaccine development/demonstration, as well as corona related testing and diagnosis.
Read Answer Asked by Vinod on April 06, 2020
Q: The company said in its last release that they will get their new product tested on live covid-19. Once this is done they will re-release the results for clarification. Assuming it works, should we see another good bump in the stock price. Is it highly likely a larger company will make a deal with them sooner than later because of its urgency or the company themselves could start mass producing it.

Thanks Steve
Read Answer Asked by Steve on April 03, 2020
Q: Apologies for repeating. Take credits freely. Two quick follow-ups to my Covalon querry. 1. I had assumed that the Saudi problems coincided with a Canadian government comment that the Saudis got offended and defensive about, not that it was a problem with COV, but with Saudis. If I remember correctly, the Saudis cancelled all contracts with Canada because of an innocent statement by a government minister. And 2, from what I have read Covid-19 is here to stay, and will return probably each year, and will need to be controlled with a vaccine, somewhat akin to flu (but more serious). We will still need Purell and anything else in the market to stay safe. I'm not trying to defend the company, but just trying to dig a bit deeper in why you don't trust the management anymore, aside from the Saudi issue. Also, the shares are in my TFSA so no tax loss benefit. The volume on the stock has always been very low, so perhaps I should let it go gradually? Again, any further insight would be much appreciated.
Read Answer Asked by Gordon on April 01, 2020
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!